Purchase of substances for pharmacological testing

The Drug Enforcement Administration (DEA) is seeking quotations for the purchase of various chemical research substances for pharmacological testing through Request for Quotation (RFQ) 15DDHQ25Q00000128. The procurement includes 19 different controlled substances and synthetic drugs in 1g/500mg quantities, including Metizolam, Deschloroetizolam, various pyrrolidinophenones, synthetic cannabinoids like delta9-THCB and delta9-THCP, and other research chemicals such as Mitragynine Pseudoindoxyl and Speciociliatine. This is a combined synopsis/solicitation prepared under FAR subparts 12.6 and 13 for commercial items, with no separate written solicitation to be issued. The contract will be awarded on a firm-fixed-price basis using the Lowest Price Technically Acceptable evaluation criteria to the vendor that provides all listed items as specified in the RFQ schedule. Quotations must be submitted via email to Kathrine.r.leach@dea.gov by September 3, 2025, at 5:00 p.m. Eastern Time.

This solicitation is unrestricted with no set-aside designation, allowing both small and large businesses to compete for the award. No incumbent contractors or potential award values are specified in the documentation, though the procurement includes a DEA Handling Fee as part of the line items. The quantities are specifically limited to 1g or 500mg amounts for each of the 19 different substances being procured. All items will be delivered to the DEA Special Testing and Research Laboratory located in Sterling, Virginia. The procurement falls under NAICS code 325412 (Pharmaceutical Preparation Manufacturing) and is classified for drugs and biologicals testing purposes. The timeline is compressed with only seven days between the posting date of August 27, 2025, and the quotation deadline of September 3, 2025.